Parvovirus B19 infection in pregnancy

被引:77
作者
de Jong, EP
de Haan, TR
Kroes, ACM
Beersmab, MFC
Oepkes, D
Walther, FJ
机构
[1] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Med Microbiol, Clin Microbiol Lab, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands
关键词
parvovirus B19; intrauterine infection; fetal anemia; intrauterine transfusion;
D O I
10.1016/j.jcv.2006.01.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Parvovirus B19 is a small single-stranded DNA virus and a potent inhibitor of erythropoiesis, Clue to its cytotoxicity to erythroid progenitor cells. Infection with parvovirus B19 during pregnancy can cause several serious complications in the fetus, such as fetal anemia, neurological anomalies, hydrops fetalis, and fetal death. Early diagnosis and treatment of intrauterine parvovirus B19 infection is essential in preventing these fetal complications. Testing maternal serum for IgM antibodies against parvovirus B19 and DNA detection by PCR can confirm maternal infection. If maternal infection has occurred, ultrasound investigation of the fetus and measurement of the peak systolic flow velocity of the middle cerebral artery are sensitive non-invasive procedures to diagnose fetal anemia and hydrops. Intrauterine transfusion is Currently the only effective treatment to alleviate fetal anemia, but if the fetus is (near) term, induction of delivery should be considered. Most maternal infections with parvovirus B19 occur through contact with infected children at home. Individual counseling Of Susceptible pregnant women will reduce unnecessary fetal deaths. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 45 条
  • [11] COSSART YE, 1975, LANCET, V1, P72
  • [12] Craze JL, 1996, DEV MED CHILD NEUROL, V38, P84
  • [13] Aetiology, Diagnosis and Treatment of Hydrops Foetalis
    de Haan, Timo R.
    Oepkes, Dick
    Beersma, Matthias F. C.
    Walther, Frans J.
    [J]. CURRENT PEDIATRIC REVIEWS, 2005, 1 (01) : 63 - 72
  • [14] Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection
    Delle Chiaie, L
    Buck, G
    Grab, D
    Terinde, R
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (03) : 232 - 236
  • [15] Long term follow up of serostatus after maternofetal parvovirus B19 infection
    Dembinski, J
    Eis-Hübinger, AM
    Maar, J
    Schild, R
    Bartmann, P
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (03) : 219 - 221
  • [16] Neurodevelopmental outcome after intrauterine red cell transfusion for Parvovirus B19-induced fetal hydrops
    Dembinski, J
    Haverkamp, F
    Maara, H
    Hansmann, M
    Eis-Hübinger, AM
    Bartmann, P
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (11) : 1232 - 1234
  • [17] Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis
    Doyle, S
    Kerr, S
    O'Keeffe, G
    O'Carroll, D
    Daly, P
    Kilty, C
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2000, 90 (02) : 143 - 152
  • [18] Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases
    Enders, M
    Weidner, A
    Zoellner, I
    Searle, K
    Enders, G
    [J]. PRENATAL DIAGNOSIS, 2004, 24 (07) : 513 - 518
  • [19] OBSERVATIONAL STUDY OF EFFECT OF INTRAUTERINE TRANSFUSIONS ON OUTCOME OF FETAL HYDROPS AFTER PARVOVIRUS B19 INFECTION
    FAIRLEY, CK
    SMOLENIEC, JS
    CAUL, OE
    MILLER, E
    [J]. LANCET, 1995, 346 (8986): : 1335 - 1337
  • [20] OCCUPATIONAL RISK OF HUMAN PARVOVIRUS-B19 INFECTION FOR SCHOOL AND DAY-CARE PERSONNEL DURING AN OUTBREAK OF ERYTHEMA-INFECTIOSUM
    GILLESPIE, SM
    CARTTER, ML
    ASCH, S
    ROKOS, JB
    GARY, GW
    TSOU, CJ
    HALL, DB
    ANDERSON, LJ
    HURWITZ, ES
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (15): : 2061 - 2065